| Detected | Trial | Change |
|---|---|---|
| 2026-07-21 | NCT06662383 A Study of Retatrutide (LY3437943) Compared to Tirzepatide (LY3298176) in Adults Who Have… |
date change Primary completion moved earlier: 2026-12 -> 2026-11 |
| 2026-07-21 | NCT07598370 A Study of LY3439539 in Participants With Alzheimer's Disease |
date change Primary completion pushed: 2027-05 -> 2027-08 |
| 2026-07-21 | NCT07598370 A Study of LY3439539 in Participants With Alzheimer's Disease |
date change Completion pushed: 2027-05 -> 2027-08 |
| 2026-07-21 | NCT07157774 Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated… |
Trial sites expanded: 769 -> 772 locations |
| 2026-07-21 | NCT06672549 A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040) |
Trial sites expanded: 50 -> 104 locations |
| 2026-07-21 | NCT07222332 A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults… |
Trial sites expanded: 133 -> 136 locations |
| 2026-07-21 | NCT06465069 A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or… |
Trial sites expanded: 35 -> 38 locations |
| 2026-07-21 | NCT07218341 A Study of Pirtobrutinib (LY3527727) in Participants With Chronic Lymphocytic… |
Trial sites reduced: 53 -> 50 locations |
| 2026-07-21 | NCT05307705 A Study of LOXO-783 in Patients With Breast Cancer/Other Solid Tumors |
overall status: "Active Not Recruiting" → "Recruiting" |
| 2026-07-21 | NCT05307705 A Study of LOXO-783 in Patients With Breast Cancer/Other Solid Tumors |
Enrollment increased: 193 -> 260 participants |
| 2026-07-19 | NCT06413706 A Study Comparing Abemaciclib Plus Temozolomide to Temozolomide Monotherapy in Children… |
date change Primary completion moved earlier: 2027-11 -> 2027-02 |
| 2026-07-19 | NCT07223593 Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease |
Trial sites expanded: 150 -> 154 locations |
| 2026-07-19 | NCT07392190 A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are… |
Trial sites reduced: 185 -> 173 locations |
| 2026-07-19 | NCT07321886 A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without… |
Trial sites reduced: 169 -> 162 locations |
| 2026-07-19 | NCT07287098 A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen… |
Trial sites expanded: 74 -> 78 locations |
| 2026-07-19 | NCT05024045 Study of Oral LOXO-338 in Patients With Advanced Blood Cancers |
Trial completed |
| 2026-07-19 | NCT05024045 Study of Oral LOXO-338 in Patients With Advanced Blood Cancers |
Enrollment reduced: 316 -> 27 participants |
| 2026-07-19 | NCT05024045 Study of Oral LOXO-338 in Patients With Advanced Blood Cancers |
date change Completion moved earlier: 2026-06 -> 2026-04-01 |
| 2026-07-17 | NCT06148272 A Study of LY3971297 in Healthy Participants |
overall status: "Recruiting" → "Active Not Recruiting" |
| 2026-07-17 | NCT07654972 A Study of LY4174794 in Participants With Obesity or Overweight Who Are Otherwise Healthy |
Recruitment opened |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-07-16 | NCT07707375 A Study of LY4268989 (MORF 057) in Healthy Participants | Phase 1 | Not Yet Recruiting |
| 2026-07-14 | NCT07701083 A Study of Eloralintide (LY3841136) in Healthy Participants | Phase 1 | Not Yet Recruiting |
| 2026-07-13 | NCT07698210 A Study of LY4178256 in Healthy Participants | Phase 1 | Not Yet Recruiting |
| 2026-06-30 | NCT07675057 Expanded Access for Vepugratinib (LY3866288) in Participants With Fibroblast Growth… | Available | |
| 2026-06-25 | NCT07668336 A Study of Orforglipron (LY3502970) Compared With Dulaglutide in Pediatric Participants… | Phase 3 | Not Yet Recruiting |
| 2026-06-24 | NCT07665879 A Study of Eloralintide (LY3841136) in Participants With Overweight or Obesity | Phase 1 | Recruiting |
| 2026-06-23 | NCT07662798 A Study of Food Effect on Tersolisib (LY4064809) in Healthy Participants | Phase 1 | Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT06876649 | A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib | Chronic Lymphocytic Leukemia | Recruiting |
| NCT06876662 | A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic… | Chronic Lymphocytic Leukemia | Recruiting |
| NCT07438444 | A Study of Tirzepatide (LY3298176) in Adult Participants in India With Either Type 2… | Diabetes Mellitus, Type 2 | Recruiting |
| NCT06857942 | A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation… | Psoriasis | Recruiting |
| NCT06864026 | A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in… | Psoriatic Arthritis | Recruiting |
| NCT07247084 | A Study of Tirzepatide (LY3298176) Compared With Standard of Care in Adult Participants… | Obesity | Recruiting |
| NCT07218341 | A Study of Pirtobrutinib (LY3527727) in Participants With Chronic Lymphocytic… | Chronic Lymphocytic Leukemia | Recruiting |
| NCT07006792 | A Study to See How Well Lebrikizumab Works in Adults and Adolescents With Moderate Atopic… | Atopic Dermatitis | Active, Not Recruiting |
| NCT07612267 | A Study to Measure Mirikizumab Levels in Breast Milk of Lactating Participants Receiving… | Lactation | Not Yet Recruiting |
| Phase 3 | |||
| NCT07035093 | A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight and… | Obesity | Recruiting |
| NCT05509777 | A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease | Crohn's Disease | Recruiting |
| NCT06339008 | A Study of Lebrikizumab in Adult Participants With Perennial Allergic Rhinitis… | Perennial Allergic Rhinitis (PAR) | Recruiting |
| NCT04844606 | A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants… | Ulcerative Colitis | Recruiting |
| NCT06937099 | Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to… | Crohn's Disease | Recruiting |
| NCT07142954 | Epidemiology and Biomarker Study in Alzheimer's Disease | Alzheimer Disease | Recruiting |
| NCT07174336 | A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in… | Breast Neoplasms | Recruiting |
| NCT07219966 | A Study of Brenipatide in Participants With Moderate-to-Severe Alcohol Use Disorder | Alcohol Use Disorder | Recruiting |
| NCT07602582 | A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM… | Alzheimer Disease | Recruiting |
| NCT07218380 | A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract | Carcinoma, Transitional Cell | Recruiting |
| NCT06890598 | Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With… | Carcinoma, Non-Small-Cell Lung | Recruiting |
| NCT03773965 | A Study of Baricitinib in Participants From 1 Year to Less Than 18 Years Old With… | Juvenile Idiopathic Arthritis | Recruiting |
| NCT05723198 | A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age… | Areata Alopecia | Recruiting |
| NCT07153471 | A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and… | Osteoarthritis | Recruiting |
| NCT07165028 | A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated… | Metabolic Dysfunction-Associated Steatotic Liver Disease | Recruiting |
| NCT07202884 | A Study of Orforglipron in Female Participants With Stress Urinary Incontinence Who Have… | Urinary Incontinence,Stress | Recruiting |